EP Patent

EP1684768A4 — METHODS OF TREATING ECZEMA

Assigned to Research Foundation of the State University of New York · Expires 2007-06-06 · 19y expired

What this patent protects

A method of treating eczema in a human or other mammal in need thereof comprising administering systemically to said human or other mammal a tetracycline compound in an amount that is effective to treat eczema, but has substantially no antibacterial activity.

USPTO Abstract

A method of treating eczema in a human or other mammal in need thereof comprising administering systemically to said human or other mammal a tetracycline compound in an amount that is effective to treat eczema, but has substantially no antibacterial activity.

Drugs covered by this patent

Patent Metadata

Patent number
EP1684768A4
Jurisdiction
EP
Classification
Expires
2007-06-06
Drug substance claim
No
Drug product claim
No
Assignee
Research Foundation of the State University of New York
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.